You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fibromatosis, Aggressive

Showing 1 - 25 of 1,656
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cryoablation for Advanced and Refractory Desmoid Tumors

Recruiting
  • Desmoid Tumors
    • Strasbourg, France
      Service d'Imagerie Interventionnelle - CHU de Strasbourg - Franc
    Oct 30, 2023

    Desmoid Tumors, Aggressive Fibromatosis Trial run by the NCI (PF-03084014)

    Active, not recruiting
    Has Results
    • Desmoid Tumors
    • Aggressive Fibromatosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 14, 2022

    Tumor Trial in Houston (Nirogacestat)

    Not yet recruiting
    • Tumor
    • Houston, Texas
      M D Anderson Cancer Center
    May 18, 2023

    Observing People With Desmoid-Type Fibromatosis

    Recruiting
    • Desmoid Fibromatosis
    • Cross-sectional imaging
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 12, 2022

    Desmoid, Desmoid Fibromatosis of Skin, Desmoid Tumor of Chest Wall Trial in Petach-Tikva (Drug Eluting Bead Embolization (DEB)

    Completed
    • Desmoid
    • +6 more
    • Drug Eluting Bead Embolization (DEB) for Desmoid Fibromatosis
    • Petach-Tikva, Israel
      Rabin Medical Center
    Mar 10, 2022

    Desmoid Tumor Trial in Palo Alto (Nirogacestat, Cryoablation)

    Not yet recruiting
    • Desmoid Tumor
    • Palo Alto, California
      Stanford University
    Jul 7, 2023

    Fibromatosis Trial in Jacksonville (Triamcinolone Acetonide)

    Completed
    • Fibromatosis
    • Triamcinolone Acetonide
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Aug 24, 2022

    Desmoid Tumor Trial in GuangZhou (Liposome doxorubicin, Saline Solution)

    Recruiting
    • Desmoid Tumor
    • Liposome doxorubicin
    • Saline Solution
    • GuangZhou, Guangdong, China
      Sun Yat-sen University cancer center
    Sep 29, 2022

    Desmoid Trial in Zhengzhou (Anlotinib)

    Not yet recruiting
    • Desmoid
    • Zhengzhou, Henan, China
      Department of Bone and Soft Tissue ,Henan Cancer Hospital
    Aug 4, 2022

    Desmoid Tumor Trial in Seoul (vactosertib/imatinib combination)

    Recruiting
    • Desmoid Tumor
    • vactosertib/imatinib combination
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Jun 14, 2022

    Soft Tissue Sarcoma, Desmoid; Abdominal Trial in Oxford (High Intensity Focused Ultrasound Ablation, Tumour Biopsy and Venous

    Recruiting
    • Soft Tissue Sarcoma
    • Desmoid; Abdominal
    • High Intensity Focused Ultrasound Ablation
    • Tumour Biopsy and Venous Blood Tests
    • Oxford, Oxfordshire, United Kingdom
      Churchill Hospital
    Jan 16, 2023

    Desmoid Trial in Bologna (Cryotherapy)

    Recruiting
    • Desmoid
    • Cryotherapy
    • Bologna, BO, Italy
      IRCCS Itituto Ortopedico Rizzoli
    Mar 25, 2022

    Desmoid Tumor Trial in United States (Sirolimus)

    Completed
    • Desmoid Tumor
    • Los Angeles, California
    • +7 more
    Jul 5, 2022

    Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease

    Recruiting
    • Desmoid
    • +3 more
    • Pregnancy
    • Boston, Massachusetts
    • +6 more
    Jan 26, 2023

    Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in

    Not yet recruiting
    • Stage I Testicular Seminoma
    • +13 more
    • Oncological Follow-up
    • Amiens, France
    • +2 more
    Aug 12, 2022

    Desmoid Tumor, NOTCH Gene Mutation Positive Tumors Trial (Nirogacestat (Gamma Secretase Inhibitor))

    Available
    • Desmoid Tumor
    • NOTCH Gene Mutation Positive Tumors
    • Nirogacestat (Gamma Secretase Inhibitor)
    • (no location specified)
    Sep 7, 2021

    Desmoid Tumor, Aggressive Fibromatosis Trial in Worldwide (Nirogacestat oral tablet, Placebo Oral Tablet)

    Active, not recruiting
    • Desmoid Tumor
    • Aggressive Fibromatosis
    • Nirogacestat oral tablet
    • Placebo Oral Tablet
    • Little Rock, Arkansas
    • +51 more
    Jan 27, 2023

    Desmoid Tumor Trial in Canada, United States (Tegavivint)

    Completed
    • Desmoid Tumor
    • Boston, Massachusetts
    • +6 more
    Jun 8, 2022

    Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood, Sarcoma, Ewing Trial in Spain (nab

    Completed
    • Tumor, Desmoplastic Small Round Cell, Adult
    • +4 more
    • nab paclitaxel
    • Barcelona, Spain
    • +6 more
    Jun 6, 2022

    Desmoid Tumor Trial in France (Cryoablation, Chemotherapy drug)

    Not yet recruiting
    • Desmoid Tumor
    • Cryoablation
    • Chemotherapy drug
    • Bordeaux, France
    • +12 more
    Oct 6, 2023

    Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic

    Active, not recruiting
    • Relapsed Pediatric Solid Tumors
    • +9 more
    • Magnetic Resonance High Intensity Focused Ultrasound
    • Washington, District of Columbia
    • +1 more
    Jan 21, 2022

    Quality of Life of Patients With Desmoid-type Fibromatosis

    Enrolling by invitation
    • Desmoid Tumor
    • Desmoid-type Fibromatosis
    • Questionnaires
    • Amsterdam, Netherlands
    • +3 more
    Mar 31, 2021

    Progressive Desmoids Tumors Trial in Bordeaux (PAZOPANIB treatment, Active Comparator: Vinblastine and Methotrexate)

    Completed
    Has Results
    • Progressive Desmoids Tumors
    • PAZOPANIB treatment
    • Active Comparator: Vinblastine and Methotrexate
    • Bordeaux, Aquitaine, France
      Institut Bergonié
    Feb 15, 2021

    Aggressive Fibromatosis Trial in France (biopsy, biobank constitution, Coloscopy)

    Active, not recruiting
    • Aggressive Fibromatosis
    • biopsy
    • +5 more
    • Angers, France
    • +37 more
    May 10, 2021

    Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut)

    Completed
    • Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) Cancer
    • +2 more
    • data collection
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jun 21, 2021